285 related articles for article (PubMed ID: 32920575)
1. Fungal profile and antifungal susceptibility pattern in patients with oral candidiasis.
Sav H; Altinbas R; Dursun ZB
Infez Med; 2020 Sep; 28(3):392-396. PubMed ID: 32920575
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
3. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
4. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
Quindós G; Carrillo-Muñoz AJ; Arévalo MP; Salgado J; Alonso-Vargas R; Rodrigo JM; Ruesga MT; Valverde A; Pemán J; Cantón E; Martín-Mazuelos E; Pontón J
Chemotherapy; 2000; 46(6):395-401. PubMed ID: 11053905
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Antifungal Susceptibility of
Mahdavi Omran S; Rezaei Dastjerdi M; Zuashkiani M; Moqarabzadeh V; Taghizadeh-Armaki M
Biomed Res Int; 2018; 2018():3086586. PubMed ID: 29888258
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
[TBL] [Abstract][Full Text] [Related]
9. Oral candidiasis in liver transplant patients: species identification and antifungal susceptibility profile.
Sabadin CES; Matta DAD; Hoppe L; Fernandes FAV; Melo ASA; Rigo L; Barbosa DA
Einstein (Sao Paulo); 2024; 22():eAO0138. PubMed ID: 38775603
[TBL] [Abstract][Full Text] [Related]
10. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S; Fındık D; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
13. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification and
Pakshir K; Zomorodian K; Zakaei A; Motamedi M; Rahimi Ghiasi M; Karamitalab M
Curr Med Mycol; 2015 Dec; 1(4):26-32. PubMed ID: 28681001
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
16. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.
Aslani N; Janbabaei G; Abastabar M; Meis JF; Babaeian M; Khodavaisy S; Boekhout T; Badali H
BMC Infect Dis; 2018 Jan; 18(1):24. PubMed ID: 29310582
[TBL] [Abstract][Full Text] [Related]
17. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
[TBL] [Abstract][Full Text] [Related]
19. Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital.
Peron IH; Reichert-Lima F; Busso-Lopes AF; Nagasako CK; Lyra L; Moretti ML; Schreiber AZ
PLoS One; 2016; 11(7):e0158126. PubMed ID: 27414653
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Moris DV; Melhem MSC; Martins MA; Souza LR; Kacew S; Szeszs MW; Carvalho LR; Pimenta-Rodrigues MV; Berghs HAM; Mendes RP
J Med Microbiol; 2012 Dec; 61(Pt 12):1758-1765. PubMed ID: 22956748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]